Arkansas Legislative Intelligence
Senate
93rd General Assembly (2021 Regular)
Passed

SB639

To Authorize Off-label Use Of Drug Treatments To Treat Patients Diagnosed With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.

To Authorize Off-label Use Of Drug Treatments To Treat Patients Diagnosed With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.

Bill Summary

To Authorize Off-label Use Of Drug Treatments To Treat Patients Diagnosed With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.
Influence Proximity
1st Degree Direct
2nd Degree Shared
3rd Degree Extended

Network Filters